Does bioaugmentation actually work?

Why the question is worth asking properly

Bioaugmentation carries a credibility burden it has earned. Enough products have been oversold over the last thirty years that a meaningful share of experienced plant operators regard the whole category as snake oil. The US EPA published a literature review on the use of commercial bioremediation agents in 2004 that is worth reading in full, precisely because it reflects the scepticism a vendor will encounter.

We sell these products, so treat this page accordingly. What follows is our attempt to set out the strongest case against the product alongside the case for it, because the alternative — writing around the scepticism — is what produced the credibility problem in the first place.

What the evidence supports

The mechanism is enzymatic hydrolysis of organic solids. Published work shows that mixtures of protease, cellulase and lipase reduce total suspended solids by 30 to 50 percent and improve settling, with protease plus cellulase outperforming either alone and lipase augmenting the effect further. One study reported 33 percent volatile suspended solids reduction.

The genus Bacillus is the single most important bacterial source of exactly those enzymes, particularly proteases. Bacillus also sporulates, which means it survives drying essentially intact. For this specific job, the organisms that do the work are precisely the organisms that dry best — so a dry format costs nothing biologically.

What the evidence does not support

The central engineering problem of the category is delivery, and it is much less well studied than the marketing suggests. A lagoon may be six to fifteen feet deep with the sludge blanket at the bottom. Bacteria applied at the surface have to get down there, survive the trip, and remain in place long enough to work.

The peer-reviewed bioaugmentation literature consistently identifies three dominant failure modes for freely suspended introduced cells: washout with effluent, predation by protozoa, and competitive exclusion by the native microbial community. Standard limnology adds a fourth consideration, which is that unmixed water bodies stratify and density gradients limit exchange between surface and bottom layers.

There is circumstantial evidence that the industry agrees delivery is the problem. At least a dozen independent manufacturers have separately engineered dense sinking or carrier-based formats specifically to place organisms into the sludge layer. Competitors converging on the same solution across two decades is reasonable evidence that the industry regards surface dosing as inadequate for bottom sludge — but convergence is not a controlled trial.

When it does not work

There are three conditions under which we would expect a programme to disappoint, and we would rather say so here than discover it with you in the field.

• The accumulation is largely inert. Bioaugmentation digests the volatile organic fraction only. Sand, grit, silt, mineral precipitates and plastics are not biodegradable and will remain regardless of dose, product or format. A lagoon that has been taking road grit or industrial mineral load for twenty years may have very little treatable material in it.
• The lagoon is poorly mixed. No vendor and no independent source claims bioaugmentation works well in a poorly mixed lagoon. Mixing and aeration are treated universally as complementary to bioaugmentation, not as alternatives to it — including by the companies selling sinking-delivery products.
• The water is cold. Spore germination is optimal between roughly 28 and 38 degrees Celsius and slows substantially below that. Biological activity resumes as water temperature passes roughly fifty degrees Fahrenheit, which is why the treatment season is a warm-season window and why cold-adapted strains are commercially valuable.

One more thing a dry product cannot do

Nitrifying bacteria — Nitrosomonas and Nitrobacter — do not survive any drying process. A dry product cannot contain viable nitrifiers, regardless of what its label implies. This matters because ammonia limits are among the most common permit pressures on municipal lagoons. If nitrogen is your problem, a dry-only product line structurally cannot address it and you need a liquid.

How to evaluate a claim, including ours

• Ask whether a published figure came from a controlled study or a vendor case study. Both appear on this page and they are labelled differently for good reason.
• Ask for a guaranteed cell count at the end of shelf life, not at manufacture. Almost nobody in this category publishes it, and it is the number that matters to the operator applying product eighteen months after it was fermented.
• Treat cell count per gram as a weak proxy for performance. What reaches the sludge is concentration multiplied by dose, and neither figure says anything about which species are present, what enzymes they produce, or whether they survive the descent.
• Ask what the vendor measured before they started. If the answer is nothing, there is no way for either of you to know whether it worked.

What the field record adds up to

Here is that policy applied to our own products. The results measured at plants treating with these formulations are collected on their own page, each with what the figure measures and what was never recorded beside it. Read as a whole rather than one flattering entry at a time, they come to this.

Each row reports one quantity rather than an average of everything published about that duty: a grease reduction and a solids reduction are different measurements, and averaging them produces a number that describes nothing. The spread inside a row is more informative than the middle of it. Where the numbers cluster, the technology is behaving predictably; where they run from the twenties to the eighties, the honest reading is that outcome depends on the lagoon rather than on the product.

Read down the last column and the useful pattern is not in the percentages at all: wastewater lagoons are the only duty with a substantial body of published solids-reduction figures behind them. Everywhere else the published record is thinner, measures something different, or measures nothing at all. That is one of the reasons the launch offer sizes lagoons and defers the rest.

The single entry worth reading twice is a municipal lagoon in Idaho: the same treatment, in the same lagoon, returned 75 per cent in one cell and 37 per cent in the other. A programme in Michigan did the same thing across three lagoons at one works, returning 40, 61 and 91 per cent. That spread is the honest shape of this technology, and it is why a dose is sized against the lagoon in front of us rather than against a brochure figure.